春节，是辞旧迎新的钟声，是阖家团圆的灯火。然而，在这万家欢聚的时刻，生活的小插曲却可能不期 而至：家里的老人可能在新春佳节突感风寒，头疼脑热；活泼好动的孩子可能在烟花爆竹声中受到惊 吓，或是因室内外温差大而突发高烧；亦或是您自己，因为一时高兴多喝了两杯，引发肠胃不适…… 不止春节，每逢节假日，最怕的就是"身体抱恙"。当"节假日"遇上"看病"，不少市民心里都会犯嘀咕： 这时候的大医院还有专家吗？检查还能做吗？手术还能约吗？在山东潍坊的阳光融和医院的，答案是： 能！阳光融和医院用九年多的坚守，给出了一个掷地有声的承诺——假日不"打烊"，健康有"医"靠。 "四无一有"，让百姓假日看病无忧 为了让市民在节假日也能享受到同质化的医疗服务，阳光融和医院自2016年开诊以来，便打破传统医疗 惯例，坚定推行"无假日医疗"。2021年，医院更是创新升级，着力打造独具特色的 "四无一有"服务模 式，彻底解决了群众节假日看病难的"心病"： ——专家门诊无假日：阳光融和医院推行"专家门诊无假日"服务，医院不间断、全天候向市民提供正常 的医疗服务，无论工作日还是双休日、节假日，医院所有临床、医技科室每日正常开放，且保证有副高 以上专家 ...

Core Insights - The commercial health insurance sector is expanding due to policy support and market demand, with significant breakthroughs in non-standard body coverage [1] - Aixin Life Insurance is focusing on broadening the coverage of commercial health insurance, transitioning non-standard body individuals from "uninsurable" to "conditionally insurable" [1] - The company leverages its parent company’s medical resources and utilizes AI and big data to lower underwriting standards for non-standard body individuals [1] Group 1 - Aixin Life's founder emphasizes the importance of customized products for specific diseases like diabetes and hypertension, addressing the insurance pain points for individuals with pre-existing conditions [1] - The company’s cancer management plan is projected to provide health protection for 1,000 clients by 2025 [1] Group 2 - Real-life claims cases demonstrate the effectiveness of Aixin Life's health management approach, showcasing a client who successfully managed lung nodules without surgery through the company's health management program [2] - The health management plan is based on a comprehensive approach that includes prevention, intervention, and protection, promoting standardized health management practices [2] Group 3 - There is a growing trend among insurance institutions to integrate health management into health insurance services, but the existing supply still struggles to meet the diverse needs of the large non-standard body population [3] - Aixin Life aims to continue iterating and upgrading health management products, focusing on personalized services to meet the health management and disease prevention needs of various demographics [3]

随着人口结构变化、疾病谱系变迁以及民众对健康品质需求的不断提升，单纯以疾病治疗为中心的 医疗模式已不能满足多元化的健康需求。社会办医作为公立医疗服务体系的重要补充，在这场变革中扮 演着愈发关键的角色。其中，由保险资本主导的医疗集团，因其独特的资源禀赋与商业模式，被视为重 塑产业格局的重要变量。 北大医疗作为这一领域的先行者与代表性机构，具有双重基因：一是源自北京大学医学部逾百年的 深厚学术底蕴、严谨医风与顶尖人才体系，这是其医疗品质的压舱石；二是来自中国平安集团的综合金 融资源、科技创新能力与庞大客户生态，这是其模式创新的推进器。两种不同的基因如何真正融合？险 资办医如何平衡医疗本质与市场逻辑？在医疗健康产业变革的十字路口，北大医疗如何走出一条可持续 的创新之路？针对上述问题，近日，《金融时报》记者对北大医疗董事长、平安健康险董事长兼首席执 行官朱友刚进行了专访。 《金融时报》记者：北大医疗所实践的"保险+医疗"模式，最根本的优势与核心的挑战是什么？在 实践中，北大医疗如何用好"北大底蕴"与"平安特色"？ 朱友刚：首先谈优势。险资办医，尤其是背靠大型综合金融集团办医，核心优势在于两个方面。一 是构建"支付+服 ...

在人口老龄化加速、健康保障需求持续攀升的背景下，保险行业正迎来一场深刻的转型，健康保险重要 性不断增强，已经成为连接医疗卫生等产业，发挥保险业筑牢社会保障网功能的重要险种。爱心人寿创 始人、董事长张延苓表示，健康管理服务是能够促进保险公司和被保险人双赢的举措，构建适合自身发 展模式的健康管理体系，本质上是把健康管理作为风险减量的重要手段。 张延苓女士指出，在当前各行各业面临挑战、经营环境日趋复杂的大背景下，爱心人寿仍能实现持续健 康发展，与其率先探索"预防式管理医疗"，开发健康管理类保险产品有关。通过提升健康管理服务能 力，爱心人寿一方面为客户提供"防-筛-诊-治-康"闭环式服务，另一方面通过服务获得的数据和经验促 进健康保险产品创新，在满足客户多样化需求的同时，降低疾病理赔支出成本。"健康管理服务是能够 促进保险公司、被保险人和医疗机构三赢的举措。"张延苓女士告诉记者。 张延苓女士在新年贺辞里也指出了爱心人寿2026年的发展方向。新的一年，爱心人寿会继续锚定"保险 +医疗"核心战略，持续推动商业健康保险与创新健康管理服务的深度融合，整合更多优质医疗资源， 在专病保障领域做深做精，在科技赋能上持续突破，在生态 ...

Core Viewpoint - Fosun is under significant debt pressure and is looking to its Portuguese insurance subsidiary, Fidelidade, as a potential solution through an IPO, which is crucial for the company's financial recovery and future operations [1][3]. Group 1: Debt Situation - Fosun's debt situation is alarming, with interest-bearing liabilities projected to reach 210 billion by the end of 2024 and total liabilities exceeding 538.3 billion by mid-2025 [3]. - Standard & Poor's has maintained a stable "BB-" rating for Fosun, indicating some level of confidence despite the high debt levels [3]. Group 2: Fidelidade's Financial Performance - Fidelidade has a long history of over 200 years and reported a net profit of 236 million euros, insurance revenue of 3.429 billion euros, and total assets of 20.282 billion euros in 2023, positioning it as a significant cash generator for Fosun [5]. - The current economic environment, with rising interest rates, has improved Fidelidade's profitability, allowing it to benefit from a favorable interest rate spread [7]. Group 3: Strategic Importance of Fidelidade - The insurance business provides "float" capital, which serves as free liquidity for daily operations and investment opportunities, crucial for Fosun's current strategy of financial contraction [9]. - Fidelidade's operations align well with Fosun's healthcare group, creating a synergistic "insurance + healthcare" model that supports the company's overarching goals of health, happiness, and wealth [9]. Group 4: IPO Considerations - The IPO of Fidelidade is not guaranteed success, as previous attempts by Fosun's LuzSaúde to go public were thwarted by market volatility and valuation issues [11]. - The company must balance between achieving a favorable valuation and the urgency of raising funds to address its debt situation [11]. Group 5: Conclusion - Fosun's strategy to sell a portion of Fidelidade's equity to raise funds for debt repayment is a calculated move to improve financial metrics and maintain control over a profitable asset [13]. - If the market responds positively, this approach could effectively reduce leverage and enhance profitability for Fosun [13].

Core Points - The strategic cooperation between China People's Property Insurance Company Nanjing Branch and Jiangsu Provincial Hospital marks a new chapter in collaboration, focusing on the "insurance + healthcare" innovative service model [1][4] - The partnership aims to enhance customer service capabilities, starting with exploratory cooperation in areas such as road injury treatment and health insurance client medical guidance [3] - The collaboration is a response to the "Healthy China" national strategy, aiming to create a model for cross-industry cooperation between insurance and healthcare [4] Group 1 - The signing ceremony was attended by key leaders from both organizations, highlighting the importance of this strategic partnership [1][3] - The cooperation will initially focus on specific areas and gradually expand to include management and data sharing, providing more precise and personalized services to clients [3] - Both organizations emphasize the integration of their strengths, with the insurance company providing extensive customer resources and efficient claims services, while the hospital offers advanced medical technology and clinical experience [3] Group 2 - The partnership aims to innovate in the "police-insurance-medical" linkage mechanism and explore deep cooperation in special medical services and commercial insurance with public hospitals [3] - The collaboration is expected to contribute significantly to the health and well-being of the public, aligning with national health initiatives [4]

Core Insights - Health insurance is becoming an essential supplement to basic medical insurance, particularly in the context of rising health risk awareness among the public [1] - The introduction of cardiovascular-specific medical insurance by Aixin Life and Hebei Mayo Cardiovascular Hospital aims to address the challenges faced by patients with chronic diseases, particularly those with cardiovascular conditions [1][2] Group 1: Product Launch and Impact - Aixin Life has launched a cardiovascular-specific disease medical insurance product that focuses on prevention, treatment, and rehabilitation for cardiovascular disease patients [1] - The product fills a gap in the insurance market for cardiovascular diseases in Hebei province, providing targeted health protection for the local population [1] - A case study of a patient who benefited from this insurance highlights its effectiveness, as the patient received significant financial support for treatment costs, demonstrating the product's value [2] Group 2: Future Directions and Strategy - Aixin Life plans to enhance its health management services by collaborating with local hospitals, health check-up centers, and pharmaceutical companies to offer a range of health management products targeting chronic and specific diseases [2] - The company aims to transition its business model towards "preventive management healthcare," integrating health insurance with health management to improve patient outcomes [2] - Aixin Life's chairman emphasizes the importance of disease prevention and management, indicating a commitment to expanding coverage for various diseases and creating a comprehensive health management service system [3]

Core Viewpoint - Junlong Life Insurance is experiencing rapid growth but faces significant challenges, particularly in risk management and market positioning as it expands into Shanghai amidst a contracting industry landscape [2][5]. Industry Overview - The insurance industry has seen a contraction in branch offices, with 971 closures in 2020, doubling to 2,197 in 2021, peaking at 2,966 in 2022, and reducing to 2,065 in 2023. The trend is expected to continue into 2025, with 946 closures in the first five months of 2023 [3][4]. Company Strategy - Junlong Life Insurance, established in 2008, has positioned itself as a product-driven insurer focusing on "insurance + healthcare" and has launched several innovative products, including the "Little Qinglong" critical illness insurance series [4][5]. - The opening of the Shanghai branch is seen as a strategic move to enhance regional operations and market penetration, particularly targeting the elderly and youth demographics with tailored financial products [4][5]. Financial Performance - Junlong Life's total assets have grown from 1.8 billion to over 10 billion from 2020 to 2025, marking it as a rising player in the market [5]. - The company reported a core solvency ratio of 132.67% and a comprehensive solvency ratio of 181.41% as of mid-2023, although these figures have decreased by 15.08 and 20.1 percentage points respectively since the beginning of the year [6]. Risk Assessment - The company's risk ratio stands at 46.69%, significantly higher than its peers, indicating a more aggressive approach to product pricing and potential exposure to insurance losses [6][7]. - Junlong Life's insurance risk occurrence rate is 34.07%, suggesting a reliance on competitive pricing strategies that may lead to higher risk [7]. Investment Strategy - As of mid-2023, Junlong Life's investment yield was 4.67%, ranking it first among 57 non-listed life insurance companies, while its comprehensive investment yield was 4.08%, placing it sixth [12]. - The company has adopted a cautious investment strategy, focusing on low-risk long-term bonds and emerging industry REITs, while also diversifying into equities and convertible bonds [14]. Operational Challenges - Despite achieving profitability in 2024 with a net profit of 0.46 billion, Junlong Life has faced losses in previous years and a significant decline in insurance revenue, which fell by 33.53% year-on-year in the first half of 2023 [14][15]. - The company is actively optimizing its business structure to focus on high-value, long-term insurance products, which may lead to short-term financial fluctuations but is expected to benefit long-term sustainability [15].

Core Insights - Junlong Life Insurance has officially opened its Shanghai branch, marking a significant step towards national market expansion after 17 years of operation in Fujian [1][2] - The company has transformed from a loss-making entity to a profitable one, with total assets increasing from 1.8 billion yuan in early 2020 to 10 billion yuan by August 2025, and premium income reaching nearly 2.5 billion yuan in 2024, quadrupling since 2019 [1][4] - The investment performance of Junlong Life is noteworthy, achieving a total investment return rate of 4.67% in the first half of 2025, ranking first among 59 non-listed life insurance companies [1][5] Company Strategy - The core strategy of Junlong Life revolves around a differentiated product approach combining "insurance + healthcare" and a long-term capital mindset linking primary and secondary markets [2][4] - The company has established a professional investment system, leveraging the investment background of its chairman, Wang Wenhui, who has managed nearly 25 billion yuan in funds and invested in over 200 companies [2][4] - Junlong Life aims to build an ecosystem of "proactive health management" by integrating resources from its shareholder, Jianfa Group, in healthcare and investment [2][4] Market Positioning - The establishment of the Shanghai branch is seen as a pivotal move for Junlong Life to enhance its brand influence and market coverage, leveraging Shanghai's status as a financial hub with abundant healthcare resources [8][9] - The company emphasizes a differentiated competitive strategy, focusing on innovative product offerings and high-quality service channels to meet the diverse needs of clients [8][9] Future Outlook - Junlong Life plans to focus on three strategic areas: "insurance + healthcare" product strategy, collaboration with quality channels, and comprehensive digitalization [9][10] - The company is optimistic about investment opportunities in three key sectors: digitalization and domestic substitution, life and health, and energy transition, viewing these as essential for long-term growth [9][10]

Group 1 - The core event was the launch of the "Long Life Era Peace of Mind Dental Implant White Paper" in Zhenjiang, showcasing the integration of insurance and medical services in the dental health sector [1] - The event highlighted the innovative "Zero-Sensation Implant First-Class Cabin" treatment experience, demonstrating significant advancements in dental technology and service upgrades by the company [1][5] - The company aims to provide a comprehensive dental health solution through its "Worry-Free Dental Implant 2.0" program, which emphasizes rapid compensation and long-term maintenance for elderly patients [2][4] Group 2 - The company has developed a full lifecycle service model for dental implants, integrating nearly 300 implant doctors and leveraging its health ecosystem to create a collaborative clinical network [2] - The "Worry-Free Dental Implant 2.0" program represents a significant upgrade in dental insurance, focusing on preventive health management and offering over 30 dental insurance products since 2019 [2][3] - The event also included a public welfare initiative aimed at improving oral health for the elderly, combining medical resources with community support to extend dental services to a broader audience [4] Group 3 - The "Zero-Sensation Implant" technology addresses patient anxiety and pain, utilizing innovative methods such as VR for anxiety relief and long-lasting pain management solutions [5] - The company emphasizes a patient-centered approach, aiming to transform dental implants from a luxury to a durable consumer product, thereby enhancing the dignity of health for the elderly [5] - The white paper outlines a comprehensive ecosystem for dental implants, integrating high-quality services, risk management, and lifelong maintenance within the company's health ecosystem [5]